arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

ABVC Biopharma, Inc.

ABVC Health Care Biotechnology: Pharmaceutical Preparations
$0.96
Today
as of Sep 4, 16:45 ET
Last 30 days -9.43% Jul 28 → Sep 04
$0.68 $0.79 $0.90 $1.00 $1.11 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$1.00
High
$1.02
Low
$0.90
Volume
$142,448
Avg Vol
$96,549
Mkt Cap
$24M
P/E (TTM)
Beta
52w High
$3.40
52w Low
$0.71
Div Yield
Shares Out
$26M

Overview

52-week range
$0.71
$3.40
9% of range
Avg surprise (last 0)
Avg reaction (last 2)
+0.5%
50% positive
Latest IV / EM
2768%
EM ±476.6% · $3 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.82$-0.62$-0.42$-0.23$-0.03 Actual $-0.68Actual $-0.82Actual $-0.29Actual $-0.08Actual $-0.03Actual $-0.06Actual $-0.13Actual $-0.09Actual $-0.06Actual $-0.03 JunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-2M$-1M$-710,637$62,555$835,748 Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.03 financials
Mon May 18, 2026Mar/2026 $-0.06 0.0% -1.8% earnings
Tue Sep 30, 2025Sep 2025 $-0.09 financials
Wed Aug 13, 2025Jun/2025 $-0.13 earnings
Wed Apr 30, 2025Mar/2025 $-0.06 +2.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.03 financials
Sun Jun 30, 2024Jun 2024 $-0.08 financials
Sun Mar 31, 2024Mar 2024 $-0.29 financials
Sat Sep 30, 2023Sep 2023 $-0.82 financials
Fri Jun 30, 2023Jun 2023 $-0.68 financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$795,950$389,276
Cost of revenue$296
Gross profit$795,950$388,980
Operating income$-779,526$-2M$-2M$-2M$-693,005$-302,316
Net income$-736,934$-2M$-2M$-2M$-842,075$-394,769
EPS (diluted)$-0.03$-0.06$-0.09$-0.13$-0.06$-0.03

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$31,944$140,324$681,480$192,068$388,251$152,206$248,382$137,344
Inventory$11,460$11,460$11,460
Total current assets$411,729$648,848$3M$3M$3M$1M$2M$2M
Total assets$19M$20M$21M$21M$16M$15M$8M$8M
Long-term debt
Total liabilities$7M$7M$8M$7M$7M$7M$7M$6M
Total equity$10M$13M$11M$12M$9M$8M$723,959$2M

Implied volatility — last 90 days

110%1015%1920%2825%3731% Jun 09 — IV 2691% · EM ±337.1%Jun 26 — IV 1656% · EM ±317.0%Jun 29 — IV 1743% · EM ±308.9%Jun 30 — IV 110% · EM ±19.0%Jul 01 — IV 1606% · EM ±268.4%Jul 02 — IV 1597% · EM ±258.3%Jul 03 — IV 1653% · EM ±258.3%Jul 06 — IV 114% · EM ±15.8%Jul 07 — IV 506% · EM ±66.8%Jul 08 — IV 1837% · EM ±230.2%Jul 09 — IV 2715% · EM ±320.7%Jul 10 — IV 2128% · EM ±235.1%Jul 13 — IV 3731% · EM ±311.6%Jul 20 — IV 123% · EM ±29.2%Jul 21 — IV 472% · EM ±109.8%Jul 22 — IV 130% · EM ±29.7%Jul 23 — IV 2205% · EM ±495.8%Jul 27 — IV 148% · EM ±31.0%Jul 29 — IV 2472% · EM ±495.1%Jul 30 — IV 2363% · EM ±463.0%Jul 31 — IV 2419% · EM ±463.0%Aug 04 — IV 2768% · EM ±476.6%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.